AU2002216408A1 - Medicines for treatment and prevention of neurogenic pain - Google Patents

Medicines for treatment and prevention of neurogenic pain

Info

Publication number
AU2002216408A1
AU2002216408A1 AU2002216408A AU2002216408A AU2002216408A1 AU 2002216408 A1 AU2002216408 A1 AU 2002216408A1 AU 2002216408 A AU2002216408 A AU 2002216408A AU 2002216408 A AU2002216408 A AU 2002216408A AU 2002216408 A1 AU2002216408 A1 AU 2002216408A1
Authority
AU
Australia
Prior art keywords
medicines
prevention
treatment
neurogenic pain
neurogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002216408A
Inventor
Munehiro Tomikawa
Hiroshi Ueda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of AU2002216408A1 publication Critical patent/AU2002216408A1/en
Abandoned legal-status Critical Current

Links

AU2002216408A 2000-12-28 2001-12-25 Medicines for treatment and prevention of neurogenic pain Abandoned AU2002216408A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000-400679 2000-12-28

Publications (1)

Publication Number Publication Date
AU2002216408A1 true AU2002216408A1 (en) 2002-07-16

Family

ID=

Similar Documents

Publication Publication Date Title
WO2001078781A8 (en) Methods for prevention and treatment of gastrointestinal disorders
HUP0301822A3 (en) A pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migrains
EP1399171A4 (en) Medicinal herbal compounds for the prevention and treatment of diabetes
PL354168A1 (en) Pharmaceutical composition of nateglinide and another antidiabetcagent
AU2003290548A1 (en) Prevention and treatment of synucleinopathic disease
AU2002213357A1 (en) Variant igg3 rituxan r and therapeutic use thereof
IL147217A0 (en) New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain
AUPR839001A0 (en) Dosage form, device and methods of treatment
IL152553A0 (en) Compounds and methods for the treatment and prevention of bacterial infection
AU2001269314A1 (en) Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds
AU2002248319A1 (en) Pharmaceutical composition for the prevention and treatment of scar tissue
EP1356812A4 (en) Medicines for treatment and prevention of neurogenic pain
AU2300001A (en) Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease
AUPQ622600A0 (en) Treatment and/or prevention of ocular pain
HUP0300402A3 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
AU3896900A (en) Treatment of pain
AU7601400A (en) Treatment and prevention of hepatic disorders
AU2000275035A1 (en) Therapeutic and prophylactic drugs of myopia
AU2001262741A1 (en) Medicines for the prevention and treatment of neurodegenerative diseases
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
IL153439A0 (en) Medicines for the prevention and treatment of neurodegenerative diseases
AU2002222125A1 (en) Prevention and treatment of tachyphylactic response
AU2566201A (en) Compounds and methods for the treatment of pain
AU2002216408A1 (en) Medicines for treatment and prevention of neurogenic pain
AU2002210286A1 (en) Medicine intended for treatment of multiple sclerosis